WHO plans to vaccinate Africa with Moderna COVID vaccine hit stumbling block

Just 12 African countries have hit WHO’s 10% vaccination target as supply chain issues worsen

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Americas

Moderna in dispute with US govt over COVID-19 vaccine inventors

11 November 2021 Moderna is facing accusations from the US National Institute of Health that it failed to give due recognition to three scientists as inventors on its COVID-19 vaccine application.

Americas

Moderna’s COVID-19 and Zika patent applications to be investigated

8 September 2020 A US Department of Health and Human Services agency will investigate whether Moderna disclosed information on government funding in patent applications relating to its COVID-19 vaccine.

Americas

Moderna unsure of COVID-19 vaccine patent exclusivity

12 August 2020 US biotech company Moderna has said it’s possible that it may not be the first company to make the inventions claimed in its pending patent applications, which include the breakthroughs for its experimental COVID-19 vaccine.

More on this story

Americas

Moderna in dispute with US govt over COVID-19 vaccine inventors

11 November 2021 Moderna is facing accusations from the US National Institute of Health that it failed to give due recognition to three scientists as inventors on its COVID-19 vaccine application.

Americas

Moderna’s COVID-19 and Zika patent applications to be investigated

Americas

Moderna unsure of COVID-19 vaccine patent exclusivity

More on this story

Americas

Moderna in dispute with US govt over COVID-19 vaccine inventors

11 November 2021 Moderna is facing accusations from the US National Institute of Health that it failed to give due recognition to three scientists as inventors on its COVID-19 vaccine application.

Americas

Moderna’s COVID-19 and Zika patent applications to be investigated

Americas

Moderna unsure of COVID-19 vaccine patent exclusivity